US govt gives $176m to Moderna for bird flu vaccine

The US government has signed a $176 million deal with Moderna to develop an mRNA-based pandemic influenza vaccine, as reports emerge of a fifth human case of H5N1 flu linked to ongoing outbreaks ... Read More

Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ... Read More

Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine

US health officials ... The review is part of a government push to examine spending on messenger RNA-based vaccines, the technology that powered Moderna’s Covid vaccine. The bird flu shot ... Read More

US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine

including advancing the company's bird flu vaccine, as fears of a new pandemic grow. The funding will help Moderna "enhance mRNA platform capabilities so that the US is better prepared to respond ... Read More

Trump Administration Weighs Pulling Funding for Moderna Bird Flu Vaccine, Bloomberg News Reports

Trump Administration Weighs Pulling Funding for Moderna Bird Flu Vaccine, Bloomberg News Reports (Reuters ... The review is part of a government push to examine spending on messenger RNA ... Read More

Moderna squares off with US government over COVID jab patent

After being hailed as a triumph of public-private drug development, Moderna's partnership with the US government ... for the vaccine available to other producers who could make it more cheaply. Read More

Moderna norovirus vaccine trial on hold by US FDA over neurological side effect

Moderna has been banking on revenue from newer mRNA shots to make up for waning post-pandemic demand for COVID-19 vaccines and less-than-expected uptake of its respiratory syncytial virus vaccine ... Read More

US company Moderna begins work on vaccine against new SARS-CoV-2 variant ‘Omicron’

NEW YORK, November 27. /TASS/. US-based biotechnological company Moderna works on a new booster vaccine against a new SARS-CoV-2 variant, B.1.1.529, which was assigned the name ‘Omicron,’ the ... Read More

US gives conditional nod to Zoetis' bird flu vaccine for poultry

Bird flu has infected nearly 70 people in the United States ... Separately, Moderna is developing a bird flu vaccine for humans and has received about $766 million from the U.S. government ... Read More

Moderna in talks with government to build vaccine factory in Japan

Negotiations with the government ... doses of Moderna’s COVID-19 vaccine used to inoculate its citizens. Bancel said Moderna is also considering manufacturing its vaccines for the flu and ... Read More